Active substances
Ethinylestradiol + Gestodene
- SFDA 6
- NHS prices 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| GYNERA 21 TAB | 30,75 µg,µg | Coated tablet · Oral use | 21 Blister | SAR 17.65 | NCE · Prescription | BAYER AG | Valid |
| LINDYNETTE 0.075/0.03 mg Film-coated Tablet | 0.03,0.075 mg,mg | Coated tablet · Oral use | 21 Blister | SAR 18.40 | Generic · Prescription | AJA PHARMACEUTICAL INDUSTRIES | Valid |
| LUTTAGEN 0.075MG/0.03MG TABLET | 0.03,0.075 mg,mg | Tablet · Oral use | 21 Blister | SAR 17.65 | Generic · Prescription | Exeltis Healthcare S.L | Valid |
| LINDYNETTE 0.075/0.03 mg Film-coated Tablet | 0.03, 0.075 mg | Coated tablet · Oral use | 63 Blister | SAR 55.20 | Generic · Prescription | AJA PHARMACEUTICAL INDUSTRIES | Withdrawn by MAH · Not Marketed |
| MINESSE FILM COATED TABLETS | 15, 60 mg | Coated tablet · Oral use | 28 Blister | SAR 24.60 | Generic · Prescription | PFIZER | Withdrawn by MAH · Not Marketed |
| MINULET 21 TAB | 30, 75 µg | Tablet · Oral use | 21 Blister | SAR 18.40 | Generic · Prescription | WYETH | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ENDOMETRIOSIS; HYPERPROLACTINEMIA; MENOPAUSE; MENSTRUAL DISORDERS
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Ethinylestradiol 20microgram / Gestodene 75microgram tablets | £8.85 | 63 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Ethinylestradiol 30microgram / Gestodene 75microgram tablets | £6.73 | 63 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.